program logo/macu/on light

Researcher Spotlight: BrightFocus Foundation 2022 Bench-to-Bedside Award Winner Ilyas Washington, PhD

  • Video
Published on:

The BrightFocus Foundation 2022 Bench to Bedside Award recipient is Ilyas Washington, PhD, co-founder biOOrg3.14 LLC & Alkeus Pharmaceuticals, Inc. His pioneering work led to a potential new treatment for Stargardt disease, an inherited condition similar to age-related macular degeneration, that received an FDA “Breakthrough Therapy” designation. Learn more about how Dr. Washington and other BrightFocus grantees and alumni are working toward a #mindsightcure at

Don't miss out.

Receive macular degeneration breakthrough news, research updates, and inspiring stories.